Skip to main content
Log in

RP-HPLC method for the quantitative determination of fexofenadine hydrochloride in coated tablets and human serum

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Fexofenadine is a non-sedative and selective peripheral H1 receptor antagonist prescribed for allergic rhinitis and chronic urticaria. This article deals with a simple, feasible, and sensitive isocratic reverse-phase high-performance liquid chromatographic method for the determination of fexofenadine hydrochloride in bulk drug, pharmaceutical dosage forms and in human serum. The chromatography was carried out at 20 ± 2°C using two different chromatographs and five different stationary phases. The isocratic mobile phase was phosphate buffer pH 7.4 and methanol (methanol–phosphate buffer, 35:65, v/v), detection was made at 218 nm and the mobile phase flowed at 1 ml min−1. Validation parameters included linearity, accuracy, precision, specificity, limit of detection (LOD), limit of quantification (LOQ), and robustness over a linearity range 5–15 μg ml−1 according to the ICH guidelines (r > 0.9999), the inter- and intra-day precisions were relative standard deviation (RSD) < 0.8%. The system suitability was scrutinized by capacity factor, tailing factor, and number of theoretical plates (capacity factor > 2.0, tailing factor ≤ 2.0, and theoretical plates > 2000). The retention time for five different stationary phases ranged from 3.78 to 4.15 min. The LOD and LOQ for the procedure were executed on samples containing very low concentrations of analytes on two different commercial brands of detectors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Arayne MS, Sultana N, Siddiqui FA (2005) Determination and quantification of cetirizine HCl in dosage formulations by RP-HPLC. Pak J Pharm Sci 18:7–11

    Google Scholar 

  • Arayne MS, Sultana N, Nawaz M (2008) Simultaneous quantification of cefpirome and cetirizine or levocetirizine in pharmaceutical formulations and human plasma by RP-HPLC. J Anal Chem 63:881–887

    Article  CAS  Google Scholar 

  • Barnes CL, McKenzie CA, Webster KD, Poinsett-Holmes K (1993) Cetirizine: a new, non-sedating antihistamine. Ann Pharmacother 27:464–470

    CAS  PubMed  Google Scholar 

  • British Pharmacoepia (2000) Her Majesty Stationary Office, pp 342–343

  • Caballero E, Ocaña I, Azanza JR, Sádaba B (1999) Fexofenadine: a antihistaminic review of its practical characteristics. Rev Med Univ Navarra 43:93–97

    CAS  PubMed  Google Scholar 

  • CDER: Center for Drug Evaluation and Research (1994) Reviewer guidance for validation of chromatographic methods. Disponívelem: http://www.fda.gov/cder/guidance/cmc3.pdf

  • Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 53:526–534

    Article  CAS  PubMed  Google Scholar 

  • Fu I, Woolf EJ, Matuszewski BK (2004) Determination of fexofenadine in human plasma using 96-well solid phase extraction and HPLC with tandem mass spectrometric detection. J Pharm Biomed Anal 35:837–846

    Article  CAS  PubMed  Google Scholar 

  • Gazy AA, Mahgoub H, El-Yazbi FA, El-Sayed MA, Youssef RM (2002) Determination of some histamine H1 receptor antagonists in dosage forms. J Pharm Biomed Anal 30:859–867

    Article  CAS  PubMed  Google Scholar 

  • Gergov M, Robson JN, Ojanperä I, Heinonen OP, Vuori E (2001) Simultaneous screening and quantification of 18 antihistamine drugs in blood by liquid chromatography ionspray tandem mass spectrometry. Forensic Sci Int 121:108–115

    Article  CAS  PubMed  Google Scholar 

  • Gowekar NM, Pande VV, Kasture AV, Tekade AR, Chandorkar JG (2007) Spectrophotometric estimation of ambroxol and cetirizine hydrochloride from tablet dosage form. Pak J Pharm Sci 20:250–251

    CAS  PubMed  Google Scholar 

  • Hamman MA, Bruce MA, Haehner-Daniels BD, Hall SD (2001) The effect of rifampin administration on the disposition of fexofenadine. Clin Pharmacol Ther 69:114–121

    Article  CAS  PubMed  Google Scholar 

  • ICH guidelines Topic Q2 (R1) Validation of analytical procedures: methodology. www.emea.europa.eu/htms/human/ich/ichquality.htm.

  • Inomata N, Tatewaki S, Ikezawa Z (2009) Multiple H1-antihistamine-induced urticaria. J Dermatol 36:224–227

    Article  CAS  PubMed  Google Scholar 

  • Karakuş S, Küçükgüzel I, Küçükgüzel SG (2008) Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. J Pharm Biomed Anal 46:295–302 [Epub 2007 October 22]

    Google Scholar 

  • Markham A, Wagstaff AJ (1998) Fexofenadine. Drugs 55:269–274 discussion 275–276

    Article  CAS  PubMed  Google Scholar 

  • Mattila MJ, Paakkari I (1999) Variations among non-sedating antihistamines: are there real differences? Eur J Clin Pharmacol 55:85–93

    Article  CAS  PubMed  Google Scholar 

  • Milne RW, Larsen LA, Ãrgensen KLJ, Bastlund J, Stretch GR, Evans AM (2000) Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein. Pharm Res 17:1511–1515

    Article  CAS  PubMed  Google Scholar 

  • Naidong W, Shou WZ, Addison T, Maleki S, Jiang X (2002) Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases—a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE. Rapid Commun Mass Spectrom 16:1965–1975

    Article  CAS  PubMed  Google Scholar 

  • Pathak SM, Kumar AR, Musmade P, Udupa N (2008) A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma—application to preclinical pharmacokinetics. Talanta 76:338–346 [Epub 2008 March 13]

    Google Scholar 

  • Pratt C, Brown AM, Rampe D, Mason J, Russell T, Reynolds R, Ahlbrandt R (1999) Cardiovascular safety of fexofenadine HCl. Clin Exp Allergy 29:212–216

    Article  CAS  PubMed  Google Scholar 

  • Radhakrishna T, Om Reddy G (2002) Simultaneous determination of fexofenadine and its related compounds by HPLC. J Pharm Biomed Anal 29:681–690

    Article  CAS  PubMed  Google Scholar 

  • Russell T, Stoltz M, Weir S (1998) Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Clin Pharmacol Ther 64:612–621

    Article  CAS  PubMed  Google Scholar 

  • Simpson K, Jarvis B (2000) Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 59:301–321

    Article  CAS  PubMed  Google Scholar 

  • Sultana N, Arayne MS, Shamshad H (2009) In vitro studies of the interaction between cetirizine and H2 receptor antagonists using spectrophotometry and reversed-phase high-performance liquid chromatography. Med Chem Res. doi:10.1007/s00044-009-9204-x

  • Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T (2004) Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection. J Pharm Biomed Anal 35:937–942

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hina Shehnaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arayne, M.S., Sultana, N., Shehnaz, H. et al. RP-HPLC method for the quantitative determination of fexofenadine hydrochloride in coated tablets and human serum. Med Chem Res 20, 55–61 (2011). https://doi.org/10.1007/s00044-009-9285-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-009-9285-6

Keywords

Navigation